US 10087229
Peptide compound
granted A61KA61K38/00A61P
Quick answer
US patent 10087229 (Peptide compound) held by Takeda Pharmaceutical Company Limited expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61P, A61P3/04, A61P3/10